OVA1(TM) - (16991)

Reference Range(s)

Pre-menopausal
Low probability of malignancy <5.0
High probability of malignancy ≥5.0

Post-menopausal
Low probability of malignancy <4.4
High probability of malignancy ≥4.4

Clinical Significance
The OVA1™ Test is an aid to further assess the likelihood that ovarian malignancy is present when the physician's independent clinical and radiological evaluation does not indicate malignancy.

Method

The OVA1 test uses results of 5 biomarkers (β2-microglobulin, apolipoprotein A1, CA 125, transferrin, transthyretin [prealbumin]) to generate a single numerical score between 0 and 10 that indicates the likelihood of malignancy.